@brokenbanker.bsky.socialgood results from #BOOM.L Audioboom, #DSCV.L discoverIE, #PRV.L Porvair, #VTU.L Vertu Motors; big contract win for #CHG.L Chemring; continued weakness for #JHD.L James Halstead:
@sharesifysocial.bsky.social
@stevem1.bsky.socialPorvair #PRV.L 10 month TU plus capital markets day, organic growth in all three divisions, modest net cash position despite a number of acquisitions. Full yr trading anticipated slightly ahead of expectations. CMD to detail mid-term growth ambitions.
@virusesmdpi.bsky.social🧬Brincidofovir inhibits #pseudorabies virus by disrupting viral replication
Screening 2,104 FDA drugs identified brincidofovir, which gave 100% protection in mice challenged with a lethal human-origin PRV strain.
@conkers3.bsky.social✅ #PRV Porvair anticipates its FY trading to be slightly AHEAD of expectations, driven by the successful integration of Drache & the recent completion of the GV Filtri acquisition, which reported €5m revenue in 2025
✅The Group achieved 14% constant currency revenue growth in the first 9 months.
@sharesifysocial.bsky.social
@stevem1.bsky.socialPorvair #PRV.L 9 mnthTU, slightly ahead of expectations due to acqn of GV Filtri, underlying trading in line. Aerospace, Nuclear, Life Sciences and Metal Melt Quality (Aluminium/superalloys) all doing ok/good, Petrochemical and Automative subdued. Diversification working well.
@nordrare.bsky.socialNORD applauds Reps. Bilirakis, Barragán, Cammack, Auchincloss, Kean and Mullin for introducing the Priority for Pediatric Cures Act to make the Rare #Pediatric Disease #PRV Program permanent.
On behalf of children with #RareDiseases, NORD strongly urges Congress to pass this bipartisan legislation.
